Skip to content
Operation Infinite Justice – Lifestyle
Author:
Zhongshan Kangfang Biological Medicine Co., LTD
Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results
March 4, 2026